StonvexLoading…
StonvexStonvexStonvexCore line items from UHS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.50B | $17.36B | $12.88B | $8.38B |
Operating Income | $502.86M | $1.99B | $1.48B | $955.10M |
Net Income | $348.68M | $1.49B | $1.04B | $669.90M |
EPS (Diluted) | $5.65 | $23.10 | $16.07 | $10.23 |
Total Assets | $15.68B | $15.53B | $15.34B | $14.99B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $119.03M | $137.80M | $112.89M | $137.59M |
Free Cash Flow OCF − CapEx | $184.47M | $849.25M | $555.77M | $403.99M |
Shares Outstanding | 61.67M | 64.46M | 64.90M | 65.51M |